SyntheX synthexlabs.com


Public list: BIO 2016 (619) Pharma Startups (4733) Cancer Therapeutics (1136)

SyntheX aims to expand drug design for the treatment of cancer and rare diseases by implementing a platform for the discovery of new classes of therapeutics that target the weakness in cancer cells (synthetic lethality).

SyntheX aims to expand drug design for the treatment of cancer and rare diseases by implementing a platform for the discovery of new classes of therapeutics that target the weakness in cancer cells (synthetic lethality).

Company (Alive / Active)

Phone: 415-706-8701

Fax:

953 Indiana St

San Francisco, 94107
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
SyntheX $6.4M Apr 24, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related SyntheX Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Protein interfaces Aug 22, 2017 Application